Back to search

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia

Data up to Jan 2025

Published2000
Citations374
References116

Total Citations Per Year

Abstract

References (116)

The Brief Psychiatric Rating Scale

1962 • 10,683 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia

1987 • 3,683 citations

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

1994 • 3,182 citations

Recent advances in the phencyclidine model of schizophrenia

1991 • 2,886 citations

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1976 • 2,224 citations

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

1963 • 2,148 citations

Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia

1986 • 2,026 citations

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1992 • 1,958 citations

Molecular pathology of schizophrenia: more than one disease process?

1980 • 1,877 citations

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia

1991 • 1,819 citations

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

1997 • 1,743 citations

Glutamate Receptor Dysfunction and Schizophrenia

1995 • 1,682 citations

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

1999 • 1,300 citations

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

1996 • 1,275 citations

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

1997 • 1,147 citations

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1990 • 1,102 citations

Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats

1998 • 1,002 citations

Imaging Synaptic Neurotransmission within VivoBinding Competition Techniques: A Critical Review

2000 • 938 citations

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

1995 • 891 citations

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1975 • 874 citations

Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area

1992 • 832 citations

Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort

1998 • 786 citations

Increased dopamine transmission in schizophrenia: relationship to illness phases

1999 • 713 citations

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1993 • 713 citations

Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia

1997 • 665 citations

Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

1999 • 593 citations

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats

1989 • 562 citations

Provocative tests with psychostimulant drugs in schizophrenia

1987 • 535 citations

Phencyclidine-induced psychosis

1978 • 482 citations

Pharmacology of mesocortical dopamine neurons.

1983 • 478 citations

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.

1970 • 475 citations

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

1999 • 452 citations

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine

1996 • 450 citations

Prefrontal function in schizophrenia: confounds and controversies

1996 • 420 citations

Advances in pharmacology

1962 • 412 citations

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1997 • 393 citations

Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo

1993 • 386 citations

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia

1985 • 373 citations

The Prefrontal Cortex Regulates the Basal Release of Dopamine in the Limbic Striatum: An Effect Mediated by Ventral Tegmental Area

1996 • 365 citations

Tonic Activation of NMDA Receptors Causes Spontaneous Burst Discharge of Rat Midbrain Dopamine Neurons In Vivo

1993 • 350 citations

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

1997 • 349 citations

The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies

2000 • 332 citations

SPECT imaging of striatal dopamine release after amphetamine challenge.

1995 • 330 citations

Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area

1992 • 315 citations

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress

1990 • 308 citations

Neurotransmitter interactions in schizophrenia—therapeutic implications

1999 • 305 citations

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1991 • 287 citations

Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices

1988 • 281 citations

Dopaminergic Mechanisms in Idiopathic and Drug-induced Psychoses

1990 • 279 citations

Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro

1987 • 239 citations

Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area

1985 • 231 citations

Iontophoretically administered drugs acting at the N‐methyl‐D‐aspartate receptor modulate burst firing in A9 dopamine neurons in the rat

1992 • 219 citations

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans

2000 • 217 citations

Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes.

1989 • 216 citations

N-methyl-d-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens

1997 • 211 citations

Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects

1998 • 199 citations

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach

1998 • 197 citations

Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine

1997 • 197 citations

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1984 • 181 citations

d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway

1978 • 165 citations

Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion

1998 • 162 citations

Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neurons

1990 • 157 citations

A glutamatergic deficiency model of schizophrenia

1999 • 155 citations

Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5-HT2 Receptor and α1-Adrenoreceptor Antagonism

1995 • 154 citations

The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.

1998 • 151 citations

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1996 • 143 citations

Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response

1987 • 133 citations

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

1992 • 130 citations

Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens

1998 • 129 citations

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

1996 • 125 citations

Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat

1995 • 123 citations

MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists

1993 • 122 citations

Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

1994 • 120 citations

Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells

1998 • 116 citations

Evidence for N-methyl-d-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-d-aspartate receptors

1995 • 113 citations

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

1993 • 111 citations

The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain

1998 • 109 citations

Ketamine and the conscious mind

1972 • 107 citations

Electrophysiological effects of selective ?-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons

1989 • 106 citations

The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study

1993 • 106 citations

SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters

1994 • 104 citations

CNS stimulants as tools in the study of schizophrenia

1984 • 100 citations

m-Chlorophenylpiperazine Effects in Neuroleptic-Free Schizophrenic Patients

1993 • 99 citations

Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: Anin vivo neurochemical assessment in the rhesus monkey

1995 • 93 citations

MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study

1991 • 92 citations

MK-801 elevates the etracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1993 • 92 citations

Regulation of glutamate efflux by excitatory amino acid receptors: evidence for tonic inhibitory and phasic excitatory regulation.

1995 • 91 citations

Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.

1994 • 90 citations

The effect of phencyclidine on dopamine synthesis and metabolism in rat striatum

1980 • 85 citations

Rating scales in research: The case of negative symptoms

1987 • 85 citations

The binding of ketamine to plasma proteins: Emphasis on human plasma

1983 • 85 citations

Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus

1999 • 84 citations

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

1999 • 82 citations

Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)

1993 • 80 citations

Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966

1997 • 77 citations

Effect of MK-801 on endogenous dopamine release in vivo

1990 • 77 citations

Glutamate pharmacology and the treatment of schizophrenia: current status and future directions

1995 • 73 citations

Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat

1986 • 68 citations

Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis

1992 • 63 citations

Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.

1994 • 58 citations

Determination of amphetamine, methamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry

1993 • 48 citations

Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl) guanidine on non-dopaminergic midbrain neurons

1993 • 47 citations

Clinical processes and central dopaminergic activity in psychotic disorders.

1980 • 44 citations

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

1995 • 43 citations

Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing

1990 • 42 citations

Peracetic acid as a superior oxidant for preparation of [123I]IBZM: A potential dopamine D‐2 receptor imaging agent

1989 • 38 citations

Recent Advances in the Teaching of Physics

1904 • 36 citations

σ and PCP receptors in human frontal cortex membranes

1988 • 32 citations

Neuronal responses to iontophoretically applied dopamine, glutamate, and GABA of identified dopaminergic cells in the rat substantia nigra after kainic acid-induced destruction of the striatum

1982 • 32 citations

Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine

1998 • 31 citations

The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity

1990 • 15 citations

Interactions between Catecholamines and Serotonin: Relevance to the Pharmacology of Schizophrenia

1997 • 14 citations

Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex

1989 • 13 citations

Synthesis of [123I]IBZM: a reliable procedure for routine clinical studies

1999 • 10 citations

Glutamate pharmacology and the treatment of schizophrenia

1995 • 4 citations

Cited By (0)

Loading...
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans:… (2000) – Biological Psychiatry | Metascience Observatory Explorer